<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1803210612
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PHENYLEPHRINE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PHENYLEPHRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        µ/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection in pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        453.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LABORATOIRE AGUETTANT" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LABORATOIRE AGUETTANT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AGUETTANT LABORATORIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C01C
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine belongs to a group of adrenergic and dopaminergic agents.</p><p>It is used to treat low blood pressure during anesthesia.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Never use PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe:<br />-&nbsp;&nbsp; &nbsp;if you are allergic to phenylephrine hydrochloride or any of the other ingredients of this medicine (listed in section 6);<br />-&nbsp;&nbsp; &nbsp;if you suffer from severe high blood pressure, or peripheral vascular disease (poor blood circulation);<br />-&nbsp;&nbsp; &nbsp;if you are taking a Monoamine Oxydase inhibitor (MAO) (or within 2 weeks of their withdrawal), that is used to treat depression (such as iproniazide, nialamide);<br />-&nbsp;&nbsp; &nbsp;if you suffer from severe overactive thyroid gland (hyperthyroidism).</p><p>&nbsp;&nbsp; &nbsp;Warnings and precautions<br />Talk to your doctor or pharmacist before using PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe. Monitor arterial and venous blood pressure during treatment.</p><p>Caution is recommended:<br />-&nbsp;&nbsp; &nbsp;if you are elderly;<br />-&nbsp;&nbsp; &nbsp;if you are diabetic;<br />-&nbsp;&nbsp; &nbsp;if you suffer from arterial hypertension;&nbsp;<br />-&nbsp;&nbsp; &nbsp;if you have an overactive thyroid gland (uncontrolled hyperthyroidism);<br />-&nbsp;&nbsp; &nbsp;if you have blood vessel disease, such as arteriosclerosis (hardening and thickening of the walls of the blood vessels);<br />-&nbsp;&nbsp; &nbsp;if you have a poor blood circulation in the brain;<br />-&nbsp;&nbsp; &nbsp;if you suffer from heart disease including chronic heart conditions, peripheral vascular insufficiency, heart rhythm disorders, tachycardia (high heart rate), bradycardia (low heart rate), partial heart block, angina pectoris;<br />-&nbsp;&nbsp; &nbsp;if you suffer from a closed angle glaucoma (a rare eye disease).</p><p>In patients with serious heart failure, phenylephrine may worsen the heart failure as a consequence of blood vessel constriction.</p><p>The blood pressure in your arteries will be monitored during treatment. If you have heart disease, additional monitoring of vital functions will be performed.</p><p>Children<br />This medicine is not recommended for use in children due to insufficient data on efficacy, safety and dosage recommendations.</p><p>Other medicines and PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe&nbsp;<br />Tell your doctor if you are using, have recently used or might use any other medicines, such as:&nbsp;<br />-&nbsp;&nbsp; &nbsp;certain antidepressants (iproniazid, nialamide, moclobenide, toloxatone, imipramine, milnacipran or venlafaxine);<br />-&nbsp;&nbsp; &nbsp;medicine used to treat infections (linezolid);&nbsp;<br />-&nbsp;&nbsp; &nbsp;certain medicines used to treat migraine (dihydroergotamine, ergotamine, methylergometrine, methylsergide);<br />-&nbsp;&nbsp; &nbsp;certain medicines used to treat Parkinson disease (bromocriptine, lisuride, pergolide);<br />-&nbsp;&nbsp; &nbsp;medicine used to inhibit the production of an hormone responsible of lactation (cabergoline);&nbsp;<br />-&nbsp;&nbsp; &nbsp;anaesthetics that are inhaled (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane);<br />-&nbsp;&nbsp; &nbsp;medicine used as an appetite suppressant (sibutramine);<br />-&nbsp;&nbsp; &nbsp;medicine used to treat high blood pressure (guanethidine);<br />-&nbsp;&nbsp; &nbsp;medicines used to treat heart failure and certain irregular heartbeats (cardiac glycosides);<br />-&nbsp;&nbsp; &nbsp;medicine used to treat abnormal heart rhythm (quinidine);<br />-&nbsp;&nbsp; &nbsp;medicine used during labour (oxytocin).</p><p>PHENYLEPHRINE AGUETTANT, 50 micrograms/ml solution for injection in pre-filled syringe, with food and drinks<br />Not applicable.</p><p>Pregnancy and breast-feeding<br />The safety of this medicine during pregnancy and breast-feeding has not been established, but the use of Phenylephrine Injection is possible during pregnancy in accordance with the indications.&nbsp;</p><p>Use of this medicine during breast-feeding is not recommended. However, in the event of a single administration during childbirth, breast-feeding is possible.</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before being given this medicine.</p><p>Driving and using machines<br />This medicinal product is not compatible with driving a vehicle or operating machinery.</p><p>PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe contains sodium<br />This medicine contains 37.2 mg sodium (main component of cooking/table salt) in each syringe. This is equivalent to 1.9% of the recommended maximum daily dietary intake of sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The administration will be performed by a healthcare professional with appropriate training and relevant experience, who will decide the correct dosage for you and when and how the injection should be administered.</p><p>The recommended doses are:<br />Use in Adults<br />Your doctor will determine the dose to be administered, and may repeat or adjust it until the desired effect is attained.</p><p>Use in patients with impaired renal function (kidneys not functioning well)&nbsp;<br />Lower doses of phenylephrine may be needed in patients with impaired renal function.</p><p>Use in patients with impaired liver function (liver not functioning well)<br />Higher doses of phenylephrine may be needed in patients with cirrhosis of the liver.</p><p>Use in older people<br />Treatment in older people should be carried out with care.</p><p>Use in children<br />This medicine is not recommended for use in children due to insufficient data on efficacy, safety and dosage recommendations..</p><p>If you have been given more PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe than you should:&nbsp;<br />You may have the following symptoms: palpitation, cardiac rhythm disorders (tachycardia, cardiac arrhythmias).&nbsp;</p><p>If you forget to use more PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe<br />Not applicable.</p><p>If you stop using PHENYLEPHRINE 50 micrograms/ml solution for injection in pre-filled syringe&nbsp;<br />Not applicable.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Some side effects may be serious (frequencies are not known). Tell your doctor straight away if you get any of the following:<br />-&nbsp;&nbsp; &nbsp;chest pain or pain due to the angina,&nbsp;<br />-&nbsp;&nbsp; &nbsp;irregular heartbeat,<br />-&nbsp;&nbsp; &nbsp;feeling the heart pumping in the chest,&nbsp;<br />-&nbsp;&nbsp; &nbsp;bleeding in the brain (speech disorder, dizziness, paralysis of one side of the body);<br />-&nbsp;&nbsp; &nbsp;psychosis (loosing contact with reality),</p><p>Other side effects may include (frequencies are not known):<br />-&nbsp;&nbsp; &nbsp;reaction of hypersensitivity (allergy),<br />-&nbsp;&nbsp; &nbsp;excessive dilation of the pupils,&nbsp;<br />-&nbsp;&nbsp; &nbsp;increased pressure in the eye (aggravation of glaucoma),&nbsp;<br />-&nbsp;&nbsp; &nbsp;excitability (excessive sensitivity of an organ or body part),&nbsp;<br />-&nbsp;&nbsp; &nbsp;agitation (restlessness),&nbsp;<br />-&nbsp;&nbsp; &nbsp;anxiety,&nbsp;<br />-&nbsp;&nbsp; &nbsp;confusion,&nbsp;<br />-&nbsp;&nbsp; &nbsp;headache;&nbsp;<br />-&nbsp;&nbsp; &nbsp;nervousness,&nbsp;<br />-&nbsp;&nbsp; &nbsp;insomnia (difficulty falling or staying asleep),&nbsp;<br />-&nbsp;&nbsp; &nbsp;shaking (tremor),&nbsp;<br />-&nbsp;&nbsp; &nbsp;burning of the skin,&nbsp;<br />-&nbsp;&nbsp; &nbsp;prickling of the skin,&nbsp;<br />-&nbsp;&nbsp; &nbsp;itching or tingling skin sensation (paresthesia),<br />-&nbsp;&nbsp; &nbsp;slow or high heart rate,&nbsp;<br />-&nbsp;&nbsp; &nbsp; high blood pressure,&nbsp;<br />-&nbsp;&nbsp; &nbsp;difficulty in breathing,&nbsp;<br />-&nbsp;&nbsp; &nbsp;fluids in the lung;<br />-&nbsp;&nbsp; &nbsp;nausea,&nbsp;<br />-&nbsp;&nbsp; &nbsp;vomiting;<br />-&nbsp;&nbsp; &nbsp;sweating,&nbsp;<br />-&nbsp;&nbsp; &nbsp;pallor or skin blanching (pale colour of the skin),&nbsp;<br />-&nbsp;&nbsp; &nbsp;goose flesh,&nbsp;<br />-&nbsp;&nbsp; &nbsp;tissue damage at the site of the injection;<br />-&nbsp;&nbsp; &nbsp;muscle weakness;<br />-&nbsp;&nbsp; &nbsp;difficulty in passing urine or urine retention&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;&nbsp; &nbsp;Store below 30&deg;C.<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;Keep this medicine out of the sight and reach of children.<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;You should not be given this medicine after the expiry date which is stated on the syringe, the blister and the carton. The expiry date refers to the last day of that month. Your doctor or nurse will check this.<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;Keep the syringe in its unopened blister, in the outer box, in order to protect from light.&nbsp;<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;Any syringe, even partially used, should be discarded appropriately after use.&nbsp;<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;Do not use this medicine if you notice visible signs of deterioration.<br />&nbsp;&nbsp; &nbsp;<br />&nbsp;&nbsp; &nbsp;Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;&nbsp; &nbsp;The active ingredient is phenylephrine (as hydrochloride).<br />-&nbsp;&nbsp; &nbsp;Each ml of solution for injection contains phenylephrine hydrochloride, equivalent to 50 micrograms phenylephrine.<br />-&nbsp;&nbsp; &nbsp;Each 10 ml pre-filled syringe contains phenylephrine hydrochloride, equivalent to 500 micrograms phenylephrine.</p><p>-&nbsp;&nbsp; &nbsp;The other ingredients are sodium chloride, sodium citrate dihydrate, citric acid monohydrate, sodium hydroxide, and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicinal product is a clear colorless solution for injection, in a 10 ml (polypropylene) pre-filled syringe for single use. 

Boxes of 10 pre-filled syringes.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>LABORATOIRE AGUETTANT<br />1, rue Alexander Fleming<br />69007 LYON&nbsp;<br />France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 01/2019.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة إلى مجموعة من الأدوية تسمى الأدوية الأدرينالية والدوبامينية.</p><p dir="RTL">يُستخدم هذا الدواء في علاج انخفاض ضغط الدم أثناء التخدير. &nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب أن لا تتلقى إطلاقًا فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة إذا:<br />- كان لديك حساسية نحو فينيليفرين هيدروكلوريد أو أيّ من المكونات الأخرى لهذا الدواء (المذكورة في الفقرة<br />&nbsp;&nbsp; رقم 6)؛</p><p dir="RTL">- كنت تعاني من ارتفاع شديد في ضغط الدم أو من أمراض الأوعية الدموية الطرفية (ضعف الدورة الدموية)؛</p><p dir="RTL">- كنت تتناول مثبط الأكسيداز أحادي الأمين (MAOI) &nbsp;(أو خلال أسبوعين من التوقف عن استخدامه)، التي<br />&nbsp;&nbsp; تُستخدم لعلاج الاكتئاب (مثل إبرونيازيد، بيالاميد)؛</p><p>- كنت تعاني من فرط نشاط الغدة الدرقية (فرط الدرقية).</p><p dir="RTL"><br /><strong>المحاذير والإحتياطات</strong><br />تحدّث إلى طبيبك أو الصيدلي قبل استخدام فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة. ينبغي مراقبة ضغط الدم الشرياني والوريدي أثناء العلاج.</p><p dir="RTL"><strong>يُنصح بالتزام الحذر خاصة إذا:</strong></p><p dir="RTL">- كنتَ من كبار السن؛</p><p dir="RTL">- كنت مصابًا بالسكري؛</p><p dir="RTL">- كنت تعاني من ارتفاع ضغط الدم الشرياني؛</p><p dir="RTL">- كان لديك فرط في نشاط الغدة الدرقية (فرط نشاط الغدة الدرقية غير المنضبط)؛</p><p dir="RTL">- إذا كنت تعاني من مرض في الأوعية الدموية، مثل تصلب الشرايين (تصلب وتسمّك جدران الأوعية<br />&nbsp;&nbsp; الدموية)؛</p><p dir="RTL">- كنت تعاني من ضعف الدورة الدموية في الدماغ؛</p><p dir="RTL">- إذا كنت تعاني من أمراض القلب بما في ذلك أمراض القلب المزمنة، قصور الأوعية الدموية المحيطية،<br />&nbsp;&nbsp; اضطرابات ضربات القلب، تسارع القلب (ارتفاع معدل ضربات القلب)، بطء القلب (انخفاض معدل<br />&nbsp;&nbsp; ضربات القلب)، إحصار القلب الجزئي، الذبحة الصدرية؛</p><p dir="RTL">- كنت تعاني من جلوكوما الزاوية المُغلقة (مرض نادر في العين).</p><p dir="RTL">قد يتسبب فينيليفرين في تفاقم قصور القلب لدى المرضى الذين يعانون من قصور قلبي شديد، وذلك نتيجة لانقباض الأوعية الدموية.</p><p dir="RTL">سيتم مراقبة ضغط الدم الشرياني لديك أثناء العلاج. وإذا كنت تعاني من أمراض القلب، فسيتم إجراء مراقبة إضافية للوظائف الحيوية كذلك<strong>.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا يُنصح باستخدام هذا الدواء عند الأطفال بسبب عدم كفاية البيانات المتعلقة بتوصيات الفعالية والسلامة والجرعة.</p><p dir="RTL"><strong>الأدوية الأخرى وفينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة</strong><br />أخبر طبيبك إذا كنت تتناول أو تناولت مؤخراً أو قد تتناول أي أدوية أخرى مثل:</p><p dir="RTL">- بعض مضادات الاكتئاب (إيبرونيازيد، نيالاميد، موكلوبيميد، تولوكساتون، إيميبرامين، ميلناسيبران أو<br />&nbsp;&nbsp; فينلافاكسين)؛</p><p dir="RTL">- الأدوية المستخدمة لعلاج الالتهابات (لينزوليد)؛</p><p dir="RTL">- بعض الأدوية المستخدمة لعلاج الصداع النصفي (ثُنائي هيدروأرغوتامين، الأرغوتامين، ميثيل إرغومِترين،<br />&nbsp;&nbsp; ميثيسيرْجيد)؛</p><p dir="RTL">- بعض الأدوية المستخدمة لعلاج مرض باركنسون (البروموكريبتين، الليسوريد، بيرجوليد)؛</p><p dir="RTL">- الأدوية المستخدمة لمنع إنتاج هرمون الرضاعة (كابيرجولين)؛</p><p dir="RTL">- أدوية التخدير التي يتم استنشاقها (ديسفلوران، إنفلوران، هالوثان، إيزوفلورين، ميثوكسي فلوران،<br />&nbsp;&nbsp; سيفوفلوران)؛</p><p dir="RTL">- الأدوية المستخدمة كمثبط للشهية (سيبوترامين)؛</p><p dir="RTL">- الأدوية المستخدمة لعلاج ارتفاع ضغط الدم (غوانيثيدين)؛</p><p dir="RTL">- الأدوية المستخدمة لعلاج قصور القلب وبعض أنواع اضطرابات ضربات القلب (جليكوسيدات القلب)؛</p><p dir="RTL">- الأدوية المستخدمة لعلاج اضطراب ضربات القلب (الكينيدين)؛</p><p dir="RTL">- الأدوية المستخدمة أثناء المخاض (الأوكسيتوسين).</p><p dir="RTL"><strong>فينيلبرين أدويتانت، 50 ميكروجرام/مل محلول للحقن في محقنة مُسبقة التعبئة، مع الطعام والشراب </strong></p><p dir="RTL">لاينطبق.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">لم يتم إثبات سلامة هذا الدواء أثناء الحمل والرضاعة الطبيعية، لكن يمكن استخدام حقنة فينيليفرين أثناء الحمل وفقًا لدواعي الاستخدام.<br />&nbsp;</p><p dir="RTL">لا يُنصح باستخدام هذا الدواء أثناء الرضاعة الطبيعية. ولكن، في حالة تلقي جرعة واحدة أثناء الولادة، يمكن معها ممارسة الرضاعة الطبيعية.<br />&nbsp;</p><p dir="RTL">إذا كنتِ حاملاً أو مرضعة، تعتقدين أنك قد تكونين حاملاً أو تخططين لإنجاب طفل، استشيري طبيبك أو الصيدلي أو الممرض قبل تلقيكِ لهذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">هذا المنتج الطبي لا يتوافق مع قيادة السيارة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيقوم أحد أخصائي الرعاية الصحية ممن لديه الخبرة والتدريب المناسب بحقن هذا الدواء لك. وسيتعيّن عليه تحديد الجرعة الصحيحة لك ومتى وكيف يجب الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعات الموصى بها هي:</strong></p><p dir="RTL"><strong>الاستخدام لدى البالغين</strong></p><p dir="RTL">سيحدد طبيبك الجرعة المراد إعطاؤها، وقد يكررها أو يعدلها حتى يتحقق التأثير المطلوب.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام لدى المرضى الذين يعانون من ضعف وظائف الكلى (حين لا تعمل الكلى بشكل جيد)</strong></p><p dir="RTL">قد تكون هناك حاجة لإعطاء جرعات أقل من فينيليفرين لدى المرضى الذين يعانون من ضعف وظائف الكلى.<br /><br /><strong>الاستخدام لدى المرضى الذين يعانون من ضعف وظائف الكبد (حين لا يعمل الكبد بشكل جيد)</strong></p><p dir="RTL">قد تكون هناك حاجة لإعطاء جرعات أعلى من فينيليفرين لدى المرضى الذين يعانون من تليف الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام لدى كبار السن</strong></p><p dir="RTL">يجب استخدامه بحذر في علاج كبار السن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام لدى الأطفال</strong></p><p dir="RTL">لا يُنصح باستخدام هذا الدواء لدى الأطفال بسبب عدم كفاية البيانات المتعلقة بتوصيات الفعالية والسلامة والجرعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تلقيت أكثر مما ينبغي من</strong> <strong>فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة</strong></p><p dir="RTL">قد تواجه الأعراض التالية: خفقان، اضطرابات ضربات القلب (تسارع ضربات القلب، اضطراب نظم &nbsp;القلب).<br />&nbsp;</p><p dir="RTL"><strong>إذا نسيت استخدام فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة</strong></p><p dir="RTL">لا ينطبق</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن استخدام</strong> <strong>فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة</strong></p><p dir="RTL">لا ينطبق</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع سائر الأدوية، يمكن أن يسبب هذا الدواء أعراضًا جانبية، على الرغم من أنها لا تحدث لدى جميع من يستخدمه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قد تكون بعض الأعراض الجانبية خطيرة (تكرار حدوثها غير معروف). أخبر طبيبك على الفور إذا تعرّضت لأي مما يلي:</strong></p><p dir="RTL">- ألم في الصدر أو ألم بسبب الذبحة الصدرية،</p><p dir="RTL">- عدم انتظام ضربات القلب،</p><p dir="RTL">- الشعور بضربات القلب في الصدر،</p><p dir="RTL">- نزيف في الدماغ (اضطراب الكلام، الدوخة، الشلل في جانب واحد من الجسم)؛</p><p dir="RTL">- الذهان (الانفصال عن الواقع)،</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تشمل الآثار الجانبية الأخرى (تكرار حدوثها غير معروف) ما يلي:</p><p dir="RTL">- فرط الحساسية (الحساسية)،</p><p dir="RTL">- التمدد المفرط لحدقة العين،</p><p dir="RTL">- زيادة الضغط في العين (تفاقم الجلوكوما)،</p><p dir="RTL">- الاستثارة (الحساسية المفرطة لعضو أو جزء من الجسم)،</p><p dir="RTL">- الهيجان (التململ)،</p><p dir="RTL">- القلق،</p><p dir="RTL">- الارتباك،</p><p dir="RTL">- صداع الراس؛</p><p dir="RTL">- العصبية،</p><p dir="RTL">- الأرق (صعوبة في النوم أو الاستمرار فيه)،</p><p dir="RTL">- الارتجاف (رعاش)،</p><p dir="RTL">- الشعور بحرقان في الجلد،</p><p dir="RTL">- الشعور باللّسع في الجلد،</p><p dir="RTL">- الحكة أو إحساس بالوخز في الجلد (المَذَل)،</p><p dir="RTL">- انخفاض أو ارتفاع معدل ضربات القلب،</p><p dir="RTL">- ارتفاع ضغط الدم،</p><p dir="RTL">- صعوبة في التنفس،</p><p dir="RTL">- تجمّع السوائل في الرئة،</p><p dir="RTL">- الغثيان،</p><p dir="RTL">- القيء،</p><p dir="RTL">- التعرق،</p><p dir="RTL">- شحوب أو إبيضاض البشرة (لون شاحب للجلد)،</p><p dir="RTL">- لحم الأوز (جلد مُقشعّر)،</p><p dir="RTL">- تلف الأنسجة في موضع الحقن،</p><p dir="RTL">- ضعف العضلات،</p><p dir="RTL">- صعوبة في التبول أو احتباس البول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;ظروف تخزين فينيليفرين 50 ميكروجرام/مل، محلول للحقن في محقنة مُسبقة التعبئة</strong><br />- احفظه بعيدا عن مرأى وتناول الأطفال.</p><p dir="RTL">- يجب عدم إعطاؤك هذا الدواء بعد تاريخ انتهاء الصلاحية المدرج في الملصق. يشير تاريخ انتهاء<br />&nbsp;&nbsp; الصلاحية إلى اليوم الأخير من الشهر. سوف يتحقق طبيبك أو الممرض من ذلك.<br />- ينبغي التخلص من أي حقنة تم استخدامها ولو جزئيا، بشكل مناسب.</p><p dir="RTL">- لا تستخدم هذا الدواء إذا لاحظت علامات تلف واضحة عليه.</p><p dir="RTL">- لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية<br />&nbsp;&nbsp; التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">العنصر الفعّال هو فينيليفرين (على شكل هيدروكلوريد):</p><p dir="RTL">- يحتوي كل مل من محلول الحقن على فينيليفرين هيدرزكلوريد، ما يعادل 50 ميكروجرام فينيليفرين.</p><p dir="RTL">- تحتوي كل محقنة بحجم 10 مل مسبقة التعبئة على فينيليفرين هيدرزكلوريد، ما يعادل 500 ميكروجرام<br />&nbsp;&nbsp; فينيليفرين.<br />&nbsp;</p><p dir="RTL">- المكونات الأخرى هي: كلوريد الصوديوم، سترات الصوديوم ثنائي الهيدرات، حامض الستريك أحادي<br />&nbsp;&nbsp; الهيدرات، هيدروكسيد الصوديوم ، والماء المُخصّص للحقن.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذا المنتج الطبي عبارة عن محلول للحقن صافٍ عديم اللون، في محقنة (مصنوعة من مادة البولي بروبيلين) مُسبقة التعبئة بـ 10 مل ومُعدة للاستخدام مرة واحدة.<br />&nbsp;</p><p dir="RTL">تتوفّر المحاقن المسبقة التعبئة في علب يحتوي كلٍّ منها على 10 محاقن.</p><p><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">اجويتانت لابوراتوار</p><p dir="RTL">1 ، شارع الكسندر فليمنج</p><p dir="RTL">69007 ليون</p><p>فرنسا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لهذه النشرة بتاريخ: 01/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Phenylephrine…………………………………………………………………………50.00 micrograms
In the form of phenylephrine hydrochloride…………………………………………..60.90 micrograms
For 1 ml

One 10-ml pre-filled syringe contains 500 micrograms of phenylephrine (in the form of phenylephrine
hydrochloride).

Excipients with known effect: sodium.
One ml of solution for injection contains 3.72 mg of sodium, equivalent to 0.162 mmol.
One 10 ml pre-filled syringe contains 37.2 mg of sodium, equivalent to 1.62 mmol.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection in pre-filled syringe.
Clear colourless solution.
pH: 4.7 – 5.3
Osmolality: 270-300 mOsm/Kg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of hypotension during spinal, epidural or general anesthesia. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p>Intravenous bolus injection:<br />Normal dose is 50 to 100 micrograms, which can be repeated until the desired effect is attained. The doses may be increased in the case of severe hypotension, but must not exceed a bolus of 100 micrograms.</p><p>Continuous infusion:<br />Initial dose is 25 to 50 micrograms/min. Doses can be increased up to 100 micrograms/min or reduced in order to maintain systolic blood pressure close to its reference value.</p><p>Doses between 25 and 100 micrograms/min have been considered effective in maintaining maternal blood pressure.</p><p>Renal impairment<br />Lower doses of phenylephrine may be needed in patients with impaired renal function.</p><p>Hepatic Impairment<br />Higher doses of phenylephrine may be needed in patients with cirrhosis of the liver.</p><p>Older people:<br />Treatment of the elderly should be carried out with care.</p><p>Paediatric population<br />The safety and efficacy of phenylephrine in children have not been established. No data are available.</p><p>Method of administration:<br />Parenteral administration. Intravenous bolus injection or intravenous infusion. The pre-filled syringe is not suitable for use with a syringe pump.<br />Phenylephrine, 50 micrograms/ml, solution for injection should only be administered by healthcare professionals with appropriate training and relevant experience.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Phenylephrine should not be used:
-	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
-	in combination with non-selective monoamine oxidase inhibitors (MAOs) (or within 2 weeks of their withdrawal) due to risk of paroxysmal hypertension and possibly fatal hyperthermia (see section 4.5);
-	in patients with severe hypertension or peripheral vascular disease due to the risk of ischemic gangrene or vascular thrombosis;
-	in patients with severe hyperthyroidism. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The venous and arterial blood pressure should be monitored during treatment.</p><p>Phenylephrine should be administered with care to patients with:<br />-&nbsp;&nbsp; &nbsp;diabetes mellitus;<br />-&nbsp;&nbsp; &nbsp;arterial hypertension;<br />-&nbsp;&nbsp; &nbsp;uncontrolled hyperthyroidism;<br />-&nbsp;&nbsp; &nbsp;coronary heart disease and chronic heart conditions;<br />-&nbsp;&nbsp; &nbsp;non-severe peripheral vascular insufficiency,<br />-&nbsp;&nbsp; &nbsp;bradycardia;<br />-&nbsp;&nbsp; &nbsp;partial heart block;<br />-&nbsp;&nbsp; &nbsp;tachycardia;<br />-&nbsp;&nbsp; &nbsp;arrhythmias;<br />-&nbsp;&nbsp; &nbsp;angina pectoris (phenylephrine can precipitate or exacerbate angina in patients with coronary artery disease and history of angina);<br />-&nbsp;&nbsp; &nbsp;aneurysma;<br />-&nbsp;&nbsp; &nbsp;closed angle glaucoma.</p><p>Phenylephrine can induce a reduction in cardiac output. Consequently, it must be administered with<br />extreme caution to patients with arteriosclerosis, to elderly and to patients with impaired cerebral or coronary circulation.</p><p>In patients with reduced cardiac output or coronary vascular disease, vital organ functions should be closely monitored and dose reduction should be considered when systemic blood pressure is near the lower end of the target range.</p><p>In patients with serious heart failure or cardiogenic shock, phenylephrine may cause deterioration in the heart failure as a consequence of the induced vasoconstriction (increase in afterload).</p><p>Particular attention should be paid to Phenylephrine injection to avoid extravasation, since this may cause tissue necrosis.</p><p>This medicinal product contains 37.2 mg sodium per syringe, equivalent to 1.9 % of the WHO recommended maximum daily intake of 2 g sodium for an adult.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Contraindicated combinations (see section 4.3)<br />&bull;&nbsp;&nbsp; &nbsp;Non-selective MAO inhibitors<br />Paroxysmal hypertension, hyperthermia possibly fatal. Due to the long duration of action of MAOIs, this interaction is still possible 15 days after discontinuation of the MAOI.</p><p>Inadvisable combinations (see section 4.4)<br />&bull;&nbsp;&nbsp; &nbsp;Dopaminergic ergot alkaloids (bromocriptine, cabergoline, lisuride, pergolide):&nbsp;<br />Risk of vasoconstriction and/or hypertensive crisis.</p><p>&bull;&nbsp;&nbsp; &nbsp;Vasoconstrictor ergot alkaloids (dihydroergotamine, ergotamine, methylergometrine, methylsergide):&nbsp;<br />Risk of vasoconstriction and/or hypertensive crisis.</p><p>&bull;&nbsp;&nbsp; &nbsp;Tricyclic antidepressants (e.g. imipramine):&nbsp;<br />Paroxysmal hypertension with possibility of arrhythmias (inhibition of adrenaline or noradrenaline entry in sympathetic fibers).</p><p>&bull;&nbsp;&nbsp; &nbsp;Noradrenergic-serotoninergic antidepressants (minalcipram, venlafaxine):&nbsp;<br />Paroxysmal hypertension with possibility of arrhythmias (inhibition of adrenaline or noradrenaline entry in sympathetic fibers).</p><p>&bull;&nbsp;&nbsp; &nbsp;Selective type A MAO inhibitors<br />Risk of vasoconstriction and/or hypertensive crisis.</p><p>&bull;&nbsp;&nbsp; &nbsp;Linezolid:&nbsp;<br />Risk of vasoconstriction and/or hypertensive crisis.</p><p>&bull;&nbsp;&nbsp; &nbsp;Guanethidine and related products:&nbsp;<br />Substantial increase in blood pressure (hyperreactivity linked to the reduction in sympathetic tone and /or to the inhibition of adrenaline or noradrenaline entry in sympathetic fibers). If the combination cannot be avoided, use with caution lower doses of sympathomimetic agents.</p><p>&bull;&nbsp;&nbsp; &nbsp;Cardiac glycosides, quinidine:<br />Increased risk of arrhythmias.</p><p>&bull;&nbsp;&nbsp; &nbsp;Sibutramine:&nbsp;<br />Paroxysmal hypertension with possibility of arrhythmias (inhibition of adrenaline or noradrenaline entry in sympathetic fibers).</p><p>&bull;&nbsp;&nbsp; &nbsp;Halogenated volatile anaesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane):&nbsp;<br />Risk of perioperative hypertensive crisis and arrhythmia.</p><p>Combinations requiring precautions for use:<br />&bull;&nbsp;&nbsp; &nbsp;Oxytocic agents:&nbsp;<br />The effect of presso-active sympathomimetic amines is potentiated. Thus, some oxytocic agents may cause severe persistent hypertension and strokes can occur during post-partum period.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Animal studies are insufficient with respect to reproductive toxicity and teratogenicity (see section 5.3).&nbsp;<br />Administration of phenylephrine in late pregnancy or labour may potentially cause fetal hypoxia and bradycardia. Use of injectable phenylephrine is possible during pregnancy in accordance with the indications.<br />The combination with some oxytocic agents can cause severe hypertension (see section 4.5).</p><p>Breast-feeding<br />Small quantities of phenylephrine are excreted in human breast milk and oral bioavailability may be low.<br />Administering vasoconstrictors to the mother exposes the neonate to a theoretical risk of cardiovascular and neurological effects. However, in the event of a single bolus administration during childbirth, breast-feeding is possible.</p><p>Fertility<br />There is no available data concerning fertility after exposure to phenylephrine (see section 5.3).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product is not compatible with driving a vehicle or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile</p><p>The most common adverse events of phenylephrine are bradycardia, hypertensive episodes, nausea and vomiting. Hypertension is more frequent with high doses.&nbsp;<br />Bradycardia is likely due to baroreceptor-mediated vagal stimulation and consistent with the pharmacological effect of phenylephrine.</p><p>List of adverse reactions</p><p>Frequency: Not known (cannot be estimated from available data)</p><p>Immune system disorders:<br />Not known: hypersensitivity</p><p>Psychiatric disorders:<br />Not known: Anxiety, excitability, agitation, psychotic states, confusion.</p><p>Nervous system disorders<br />Not known: Headache, nervousness, insomnia, paresthesia, tremor.<br />Eye disorders:<br />Not known: Mydriasis, aggravation of pre-existing angle-closure glaucoma</p><p>Cardiac disorders:<br />Not known: Reflex bradycardia, tachycardia, palpitations, hypertension, arrhythmia, angina pectoris, myocardial ischemia.</p><p>Vascular disorders:<br />Not known: Cerebral haemorrhage, hypertensive crisis</p><p>Respiratory, thoracic and mediastinal disorders:<br />Not known: Dyspnoea, &nbsp;pulmonary oedema</p><p>Gastrointestinal disorders:<br />Not known: Nausea, vomiting</p><p>Skin and subcutaneous tissue disorders:&nbsp;<br />Not known: Sweating, pallor or skin blanching, piloerection, skin necrosis with extravasation</p><p>Musculoskeletal and connective tissue disorders:<br />Not known: muscular weakness</p><p>Renal and urinary disorders:<br />Not known: Difficulty in micturition and urinary retention</p><p>Description of selected adverse reactions<br />As phenylephrine has been frequently used in the critical care setting in patients with hypotension and shock, some of the reported serious adverse events and deaths are probably related to the underlying disease and not related to the use of phenylephrine.</p><p>Other special population(s)<br />Elderly: risk for phenylephrine toxicity is increased in elderly patients (see section 4.4).</p><p>To reports any side effect(s):</p><p>Saudi Arabia:&nbsp;</p><p>&bull;&nbsp;&nbsp; &nbsp;The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp; &nbsp;Fax: +966-11-205-7662<br />-&nbsp;&nbsp; &nbsp;Call NPC at +966-11-2038222, Ext 2317-2356-2340<br />-&nbsp;&nbsp; &nbsp;SFDA Call Center: 19999<br />-&nbsp;&nbsp; &nbsp;E-mail: npc.drug@sfda.gov.sa<br />-&nbsp;&nbsp; &nbsp;Website: https://ade.sfda.gov.sa/</p><p><br />Other GCC States:</p><p>-&nbsp;&nbsp; &nbsp;Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms of overdose include headache, nausea, vomiting, paranoid psychosis, hallucinations, hypertension and reflex bradycardia. Cardiac arrhythmia such as ventricular extrasystoles and short paroxysmal episodes of ventricular tachycardia may occur. &nbsp;</p><p>Treatment should consist of symptomatic and supportive measures. The hypertensive effects may be treated with an alpha-adrenoceptor blocking drug, such as phentolamine.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: CARDIAC STIMULANT EXCEPT CARDIAC GLYCOSIDES, ATC Code: C01CA06</p><p>Phenylephrine is a potent vasoconstrictor that acts almost exclusively by stimulating alpha-1-adrenergic receptors. Such arterial vasoconstriction is also accompanied by venous vasoconstriction. This gives an increase in blood pressure and reflex bradycardia. The potent arterial vasoconstriction gives an increase in the systemic vascular resistance (increase in afterload). The overall result is a reduction in the cardiac output. This is less pronounced in healthy people but it may worsen in cases of previous heart failure. As Phenylephrine effects are linked to its pharmacological properties, they can be controlled by known antidotes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;&nbsp; &nbsp;The volume of distribution after single dose is 340 litres.<br />&nbsp;&nbsp; &nbsp;Phenylephrine is metabolised in the liver by monoamine oxidase.<br />&nbsp;&nbsp; &nbsp;Phenylephrine is mainly excreted via the kidneys as m-hydroxymandelic acid and phenol conjugates.&nbsp;<br />&nbsp;&nbsp; &nbsp;The duration of effect is 20 minutes after intravenous administration.<br />&nbsp;&nbsp; &nbsp;The terminal half life of injectable phenyleprine is about 3 hours.<br />&nbsp;&nbsp; &nbsp;The plasma protein binding is unknown.<br />&nbsp;&nbsp; &nbsp;There is no data available on the pharmacokinetics in special patient groups.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Available non clinical data do not bring to the prescriber any additional relevant information in comparison with those already mentioned in the other sections of the SPC.&nbsp;<br />Animal studies are insufficient to evaluate effects on fertility and reproduction.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride, sodium citrate dihydrate, citric acid monohydrate, sodium hydroxide (for pH adjustment), water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Keep the syringe in its unopened blister until use. Store the blister in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10 ml polypropylene pre-filled syringe. Boxes of 10 syringes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Instructions for use:</p><p>Please prepare the syringe carefully as follows</p><p>The pre-filled syringe is for single patient only. Discard syringe after use.</p><p>The content of un-opened and un-damaged blister is sterile, and must not be opened until use.&nbsp;</p><p>When handled using an aseptic method, Phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe can be placed on a sterile field.&nbsp;</p><p>1)&nbsp;&nbsp; &nbsp;Withdraw the pre-filled syringe from the sterile blister.</p><p><br />2) Push on the plunger to free the bung. The sterilisation process may have caused adhesion of the bung to the body of the syringe.</p><p>3) Twist off the end cap to break the seal. Do not touch the exposed luer connection in order to avoid contamination.</p><p>4) Check the syringe seal tip has been completely removed. If not, replace the cap and twist again</p><p>5) Expel the air by gently pushing the plunger.<br />6) Connect the syringe to the IV access. Push the plunger slowly to inject the required volume.</p><p>7) After use, dispose of the syringe according to the practices in force in your facility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LABORATOIRE AGUETTANT
1, RUE ALEXANDER FLEMING
69007 LYON
France
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                21 January 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>